| Brian Revis, MD | |
|
2123 Auburn Ave, Ste 404, Cincinnati, OH 45219-2906 | |
| (513) 241-5630 | |
| (513) 241-7146 |
| Full Name | Brian Revis |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 18 Years |
| Location | 2123 Auburn Ave, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023219052 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 35.093306 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - Norwood Dialysis | Cincinnati, OH | Dialysis facility |
| Bethesda North | Cincinnati, OH | Hospital |
| Mercy Health - West Hospital | Cincinnati, OH | Hospital |
| Good Samaritan Hospital | Cincinnati, OH | Hospital |
| The Jewish Hospital-mercy Health | Cincinnati, OH | Hospital |
| Christ Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
News Archive
Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.
More than 15 years after Sept. 11, 2001, a majority of bereaved family members who lost a loved one in the terrorist attacks that day appear to be healthy and are not reporting symptoms of a mental health condition, while one-third still likely meet the criteria for depression, grief, and anxiety, according to a recent collaborative study led by the Uniformed Services University of the Health Sciences.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
| Entity Name | Kidney And Hypertension Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306944871 PECOS PAC ID: 9830099985 Enrollment ID: O20040113000581 |
News Archive
Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.
More than 15 years after Sept. 11, 2001, a majority of bereaved family members who lost a loved one in the terrorist attacks that day appear to be healthy and are not reporting symptoms of a mental health condition, while one-third still likely meet the criteria for depression, grief, and anxiety, according to a recent collaborative study led by the Uniformed Services University of the Health Sciences.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
| Entity Name | Dialysis Access Center Of Cincinnati, Inc. |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1427577840 PECOS PAC ID: 1456615236 Enrollment ID: O20180502001104 |
News Archive
Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.
More than 15 years after Sept. 11, 2001, a majority of bereaved family members who lost a loved one in the terrorist attacks that day appear to be healthy and are not reporting symptoms of a mental health condition, while one-third still likely meet the criteria for depression, grief, and anxiety, according to a recent collaborative study led by the Uniformed Services University of the Health Sciences.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
| Entity Name | Dialysis Access Center Of Cincinnati, Inc. |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1568079788 PECOS PAC ID: 1456615236 Enrollment ID: O20210421003042 |
News Archive
Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.
More than 15 years after Sept. 11, 2001, a majority of bereaved family members who lost a loved one in the terrorist attacks that day appear to be healthy and are not reporting symptoms of a mental health condition, while one-third still likely meet the criteria for depression, grief, and anxiety, according to a recent collaborative study led by the Uniformed Services University of the Health Sciences.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Revis, MD 4600 Montgomery Rd, Ste 105, Cincinnati, OH 45212-2697 Ph: (513) 487-5305 | Brian Revis, MD 2123 Auburn Ave, Ste 404, Cincinnati, OH 45219-2906 Ph: (513) 241-5630 |
News Archive
Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.
More than 15 years after Sept. 11, 2001, a majority of bereaved family members who lost a loved one in the terrorist attacks that day appear to be healthy and are not reporting symptoms of a mental health condition, while one-third still likely meet the criteria for depression, grief, and anxiety, according to a recent collaborative study led by the Uniformed Services University of the Health Sciences.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
Moises Arturo Huaman Joo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman Street, Cincinnati, OH 45219 Phone: 513-584-6977 Fax: 513-584-4281 | |
Dr. Kiranmayee Lanka, M.D., M.P.H Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2123 Auburn Ave, Suite 401, Cincinnati, OH 45219 Phone: 513-241-5489 Fax: 513-241-5490 | |
Dr. Saurabh Chandra, MD Nephrology Medicare: Medicare Enrolled Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-558-1000 | |
Gretchen Suarez, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 10500 Montgomery Rd, Cincinnati, OH 45242 Phone: 513-865-2246 Fax: 513-865-5596 | |
Dr. Andrew Michael Espinal, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4777 E Galbraith Rd, Cincinnati, OH 45236 Phone: 513-686-3000 | |
Sorina M Macavei, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 463 Ohio Pike, Suite 300, Cincinnati, OH 45255 Phone: 513-528-5600 Fax: 513-528-9716 | |
Helen K Koselka, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-528-5600 Fax: 513-528-9716 |